Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Nov 16, 2023
Date Accepted: Apr 29, 2024

The final, peer-reviewed published version of this preprint can be found here:

Behavioral Weight Loss Programs for Cancer Survivors Throughout Maryland: Protocol for a Pragmatic Trial and Participant Characteristics

Jerome G, Appel L, Bunyard L, Dalcin A, Durkin N, Charleston J, Norma K, Carducci M, Wang NY, Yeh HC

Behavioral Weight Loss Programs for Cancer Survivors Throughout Maryland: Protocol for a Pragmatic Trial and Participant Characteristics

JMIR Res Protoc 2024;13:e54126

DOI: 10.2196/54126

PMID: 38865181

PMCID: 11208825

Behavioral Weight Loss Programs for Cancer Survivors throughout Maryland: Protocol for a Pragmatic Trial and Participant Characteristics

  • Gerald Jerome; 
  • Lawrence Appel; 
  • Linda Bunyard; 
  • Arlene Dalcin; 
  • Nowella Durkin; 
  • Jeanne Charleston; 
  • Kanarek Norma; 
  • Michael Carducci; 
  • Nae-Yuh Wang; 
  • Hsin-Chieh Yeh

ABSTRACT

Background:

Clinical trials examining lifestyle interventions for weight loss in cancer survivors have been demonstrated to be safe, feasible, and effective. However, scalable weight loss programs are needed to support their widespread implementation.

Objective:

This study describes the study design, enrollment, and baseline characteristics of participants in the ASPIRE Study, a real-world, lifestyle-based, weight loss program for cancer survivors throughout Maryland.

Methods:

Participants were adults residing in Maryland with BMI ≥ 25 kg/m2 who reported diagnosis of a malignant solid tumor, completed curative treatment, and had no ongoing or planned cancer treatment. Enrollment criteria were kept to a minimum to increase generalizability. The primary recruitment source was the Johns Hopkins Health System electronic health records (EHR). Participants selected one of three remotely delivered weight loss programs: Self-Directed (SD), App-Supported (AS), or Coach-Supported (CS) program.

Results:

Recruitment was effective across all five geographic regions of Maryland. Targeted invitations using EHR accounted for 84.4% of the 340 participants enrolled. Of the 5,644 patients invited through EHR, 5.1% enrolled. Participants had a mean (standard deviation) age of 60.7(10.8) years, 74.7% were female, 55.9% identified as Non-Hispanic Black, 58.5% had a bachelor’s degree, and the average BMI was 34.1(5.9) kg/m2. The most common types of cancers were breast (49.4%), prostate (21.2%), and thyroid (8.5%). The SD program (n=91) included 25 participants who agreed to provide weights through a study scale; the AS program (n=142) included 108 individuals who agreed to provide weights; and the CS program included 107 participants.

Conclusions:

These results support EHR-based recruitment efforts as a pragmatic approach to reach and enroll cancer survivors into remotely delivered weight loss programs. Clinical Trial: ClinicalTrials.gov NCT04534309


 Citation

Please cite as:

Jerome G, Appel L, Bunyard L, Dalcin A, Durkin N, Charleston J, Norma K, Carducci M, Wang NY, Yeh HC

Behavioral Weight Loss Programs for Cancer Survivors Throughout Maryland: Protocol for a Pragmatic Trial and Participant Characteristics

JMIR Res Protoc 2024;13:e54126

DOI: 10.2196/54126

PMID: 38865181

PMCID: 11208825

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.